spacer
home > ict > autumn 2017 > helping hands
PUBLICATIONS
International Clinical Trials

Helping Hands

To be able to discuss how site nursing support benefits
the clinical trial industry and home care in particular, the
ongoing obstacles need to be understood. Clinical trial sites
face many challenges, such as engaging minority groups
efficiently and quickly identifying patients, while coping
with increased work load due to the small pool of available
research locations.

Equal Representation

One barrier that continues to impact clinical trials is the
enrolment of ethnic minority groups. These classes remain
underrepresented in treatment experiments that could
save their lives. However, some diseases are more prevalent
in different racial and ethnic groups – African Americans
are approximately 70% more likely to be diagnosed with
diabetes, for example (1). Therefore, to produce a drug
that will best treat these patients they must be included
in clinical trials.

This remains an obstacle for several reasons: a lack of
minority principal investigators (PI), a lack of awareness
of clinical trials among these groups or patients living too
far from an enrolling location.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Helena Baker is Vice President of Nursing at Medical Research Network and has over 32 years’ experience in nursing and healthcare. She previously worked at the Royal London Hospital in Whitechapel, Ferring Pharmaceuticals Ltd and St Bartholomew’s Hospital in the UK, as well as acting as a healthcare analyst to the pharmaceutical industry.
spacer
Helena Baker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

Philadelphia, USA – September 10, 2018 Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce the acquisition of San Diego-based Sherpa Clinical Packaging (Sherpa), which expands PCI’s U.S. operations to the West Coast. The acquisition of Sherpa, a provider of clinical trial supply services, further strengthens PCI’s position as a leader in outsourced clinical trial support services. The addition of Sherpa’s capabilities also enables PCI to better support customers from early phases of clinical development through to commercial launch.
More info >>

White Papers

The Importance of Critical Temperatures in the Freeze Drying of Pharmaceutical Products

Biopharma Group

Every formulation has a critical temperature, below which it should be cooled for complete solidification and maintained below during primary drying in order to prevent processing defects. To design a freeze drying cycle on a rational basis such information should be identified.
More info >>

 
Industry Events

Pharma and Device Packaging and Labelling West Coast 2018

27-28 November 2018, Burlingame, CA

The second edition of the Pharma and Device Packaging and Labeling West Coast was a thought-provoking two days of engaging presentations, discussion and networking.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement